Placental CYP27B1 and CYP24A1 expression in human placental tissue and their association with maternal and neonatal calcitropic hormones

J Clin Endocrinol Metab. 2014 Apr;99(4):1348-56. doi: 10.1210/jc.2013-1366. Epub 2014 Jan 28.

Abstract

Context: Placental CYP27B1 may contribute to circulating maternal calcitriol concentrations across gestation, but determinants of CYP27B1 and CYP24A1 expression in term human placental tissue are not well established.

Objective: We hypothesized that higher CYP27B1 protein expression would be associated with increased maternal calcitriol during gestation and that CYP27B1 expression would be impacted by substrate availability.

Design: This was a prospective, longitudinal study.

Setting: The study was completed in an urban, prenatal clinic located in Rochester, New York.

Patients: The study was undertaken in a cohort of 70 pregnant adolescents (≤18 y of age) and their term neonates.

Intervention: There was no intervention.

Main outcomes: Protein and mRNA expressions of CYP27B1, CYP24A1, and vitamin D receptor were measured in term placental tissue and related to 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D, PTH, serum total calcium, IL-6, leptin, and osteoprotegerin measured in maternal serum at midgestation and delivery and in umbilical cord serum at birth.

Results: Placental CYP27B1 protein expression was significantly positively associated with maternal 25(OH)D at both midgestation (n = 68, P = .009) and delivery (n=67, P = .006). Maternal serum 1,25-dihydroxyvitamin D concentrations at midgestation were positively correlated with term placental CYP27B1 mRNA expression (n = 49, P = .002). Significant positive associations were evident between placental CYP27B1 and CYP24A1 protein expression (P = .001, n = 70). Maternal PTH concentrations at midgestation or delivery did not significantly impact placental protein or transcript level of either enzyme. Variability in placental CYP27B1 protein expression was best captured by a model that included maternal midgestation 25(OH)D concentration, placental vitamin D receptor protein expression, and maternal midgestation IL-6 concentrations (P = .002, n = 60, R(2) = 0.22).

Conclusions: Higher maternal 25(OH)D during pregnancy was associated with significantly higher placental protein expression of CYP27B1 at term supportive of a link between substrate availability and placental production of calcitriol.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase / genetics*
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase / metabolism
  • Adolescent
  • Calcium / metabolism*
  • Female
  • Fetal Blood / chemistry
  • Fetal Blood / metabolism
  • Hormones / blood*
  • Humans
  • Infant, Newborn / blood
  • Interleukin-6 / blood
  • Longitudinal Studies
  • Parathyroid Hormone / blood
  • Placenta / enzymology
  • Placenta / metabolism*
  • Pregnancy
  • Receptors, Calcitriol / genetics
  • Receptors, Calcitriol / metabolism
  • Steroid Hydroxylases / genetics*
  • Steroid Hydroxylases / metabolism
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood
  • Vitamin D3 24-Hydroxylase

Substances

  • Hormones
  • Interleukin-6
  • Parathyroid Hormone
  • Receptors, Calcitriol
  • Vitamin D
  • 1,25-dihydroxyvitamin D
  • Steroid Hydroxylases
  • CYP24A1 protein, human
  • Vitamin D3 24-Hydroxylase
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
  • Calcium